U.S. markets open in 5 hours 9 minutes
  • S&P Futures

    3,628.75
    +1.50 (+0.04%)
     
  • Dow Futures

    29,834.00
    +6.00 (+0.02%)
     
  • Nasdaq Futures

    12,191.50
    +39.25 (+0.32%)
     
  • Russell 2000 Futures

    1,838.50
    -6.10 (-0.33%)
     
  • Crude Oil

    44.85
    -0.86 (-1.88%)
     
  • Gold

    1,812.40
    +1.20 (+0.07%)
     
  • Silver

    23.28
    -0.16 (-0.69%)
     
  • EUR/USD

    1.1926
    +0.0013 (+0.11%)
     
  • 10-Yr Bond

    0.8780
    -0.0040 (-0.45%)
     
  • Vix

    21.25
    -0.39 (-1.80%)
     
  • GBP/USD

    1.3367
    +0.0011 (+0.08%)
     
  • USD/JPY

    104.0860
    -0.1640 (-0.16%)
     
  • BTC-USD

    17,134.78
    -31.87 (-0.19%)
     
  • CMC Crypto 200

    335.72
    -34.79 (-9.39%)
     
  • FTSE 100

    6,362.93
    -28.16 (-0.44%)
     
  • Nikkei 225

    26,644.71
    +107.40 (+0.40%)
     

Collegium to Participate in Upcoming Investor Conference

STOUGHTON, Mass., Nov. 08, 2019 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conference in November:

  • The Jefferies 2019 London Healthcare Conference on Thursday, November 21st in London. Management will present at 2:00 p.m. GMT and will also participate in investor meetings.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
Alex Dasalla
adasalla@collegiumpharma.com